Royal London improves diabetes underwriting
Royal London has introduced a number of changes to its diabetes underwriting philosophy.
The changes are in line with the mutual insurer’s commitment to regularly enhance the most common areas of its protection underwriting disclosure. The changes will improve outcomes for customers living with type 1 diabetes and ensure type 2 diabetes loadings are appropriate.
It has also removed or reduced some of the additional loadings applied in underwriting diabetes. For example, the loading applied for the complication of background retinopathy has been reduced. In addition, it has introduced a bespoke approach for pre-diabetes allowing more customers to get a decision at the point of application.
Craig Paterson, Chief Underwriter at Royal London, said:
"The improvements to our underwriting of customers living with diabetes continues our theme of focussing on evidence-based underwriting and boosting access to protection insurance. The changes reaffirm our commitment to regularly review and enhance our offering, ensuring our customer journey is quick and efficient, and allows more people to protect themselves and their families."
For further information please contact:
Neil Cameron, PR Manager
- Email: neil.cameron@royallondon.com
- Mob: 07919 171969
About Royal London
Royal London is the largest mutual life, pensions and investment company in the UK, and in the top 30 mutuals globally*, with assets under management of £173bn, 8.7 million policies in force and over 4,500 employees. Figures quoted are as at 31 December 2024. Learn more at royallondon.com.
*Based on total 2022 premium income. ICMIF Global 500, 2024